Positive Heart Failure Trial Results Presented to AHA
Filed with ASX · · 3 pages · English
Earlier from Mesoblast
Later from Mesoblast
- Appendix 4C - Strong Cash Position
- Appendix 4D and Half Year Financial Report to 31 Dec 2010
- Cardiac Events, Mortality and Hospitalization Reduced
- FDA Clears Phase 2 Trial to Treat Degenerative Disc Disease
- Key Product Franchises Featured at Nomura Asia Equity Forum
Follow Mesoblast into a list and get an email when it puts out news.
Follow Mesoblast